Erectile Dysfunction Prevelance Forecasts in 29 Major Markets 2017-2027 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Erectile
Dysfunction Forecast in 29 Major Markets 2017-2027”
report to
their offering.

Erectile dysfunction, also known as ED and impotence, is defined as the
frequent inability to achieve or maintain an erection sufficient for
sexual activity to take place.

This report provides the current prevalent population for Erectile
Dysfunction across 29 Major Markets (USA, Canada, France, Germany,
Italy, Spain, UK, Netherlands, Portugal, Switzerland, Croatia, Poland,
Romania, Russia, Norway, Sweden, Greece, Turkey, Saudi Arabia, Egypt,
China, Japan, South Korea, India, Australia, South Africa, Brazil,
Mexico, Argentina) split 5-year age cohort. Along with the current
prevalence, the report also contains a disease overview of the risk
factors, disease diagnosis and prognosis along with specific variations
by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several
of the main symptoms and co-morbidities of Erectile Dysfunction have
been quantified and presented alongside the overall prevalence figures.
These sub-populations within the main disease are also included at a
country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Erectile Dysfunction disease

– Chronic heart disease

– Hypertension

– Diabetes


– Anaemia

– Depression

– Loss of libido

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key comorbid conditions/Features associated with the disease

8. Methodology for quantification of patient numbers

9. Top-line prevalence for Erectile Dysfunction

10. Features of Erectile Dysfunction patients

11. Abbreviations used in the report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Topics: Sexual
and Reproductive Health Drugs